×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
COLL – collegium pharmaceutical, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
COLL
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/19
07:41 pm
coll
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]
Neutral
Report
Collegium Pharmaceutical, Inc. (COLL) Discusses Acquisition of AZSTARYS to Expand ADHD Portfolio and Accelerate Growth Transcript [Seeking Alpha]
3/19
10:02 am
coll
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical to Buy AZSTARYS for $650M, Expanding ADHD Franchise Through 2037 [Yahoo! Finance]
3/19
08:00 am
coll
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
Low
Report
Collegium to Acquire AZSTARYS® from Corium Therapeutics, Strengthening Position in ADHD and Accelerating Growth Trajectory
3/14
08:12 pm
coll
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference [Yahoo! Finance]
Medium
Report
Collegium Pharmaceutical touts record 2025, sees JORNAY PM driving 2026 growth at Barclays Miami Conference [Yahoo! Finance]
3/14
08:12 pm
coll
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure [Yahoo! Finance]
Medium
Report
A Look At Collegium Pharmaceutical (COLL) Valuation After Recent Share Price Pressure [Yahoo! Finance]
3/10
09:14 am
coll
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results [Yahoo! Finance]
Low
Report
Collegium Pharmaceutical (COLL) Surged Following Record Quarterly Results [Yahoo! Finance]
3/6
06:10 pm
coll
Collegium Pharmaceutical (COLL) was downgraded by Weiss Ratings from "buy (b-)" to "hold (c+)".
Low
Report
Collegium Pharmaceutical (COLL) was downgraded by Weiss Ratings from "buy (b-)" to "hold (c+)".
3/5
08:00 am
coll
Collegium to Present New Real-World Data at PainConnect 2026
Medium
Report
Collegium to Present New Real-World Data at PainConnect 2026
Date
Time
Symbol
Company Name
Action
%Chg
2/26/2026
07:30 am
coll
collegium pharmaceutical, inc.
BEAT
Report
0.5%
collegium pharmaceutical, inc.
11/6/2025
07:30 am
coll
collegium pharmaceutical, inc.
BEAT
Report
1.1%
collegium pharmaceutical, inc.
8/7/2025
07:30 am
coll
collegium pharmaceutical, inc.
BEAT
Report
9.8%
collegium pharmaceutical, inc.
5/8/2025
04:01 pm
coll
collegium pharmaceutical, inc.
BEAT
Report
5.9%
collegium pharmaceutical, inc.
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/19
05:07 pm
coll
Form 8-K COLLEGIUM PHARMACEUTICAL For: Mar 19
Neutral
Report
Form 8-K COLLEGIUM PHARMACEUTICAL For: Mar 19
3/18
04:10 pm
coll
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dieter David
Medium
Report
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dieter David
3/11
04:10 pm
coll
Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 09 Filed by: Dieter David
Low
Report
Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 09 Filed by: Dieter David
3/9
10:39 am
coll
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dieter David
Low
Report
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dieter David
3/5
04:30 pm
coll
Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 03 Filed by: Dreyer Scott
Low
Report
Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 03 Filed by: Dreyer Scott
3/3
04:14 pm
coll
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dreyer Scott
Low
Report
Form 144 COLLEGIUM PHARMACEUTICAL Filed by: Dreyer Scott
2/26
07:35 am
coll
Form 10-K COLLEGIUM PHARMACEUTICAL For: Dec 31
Low
Report
Form 10-K COLLEGIUM PHARMACEUTICAL For: Dec 31
2/26
07:33 am
coll
Form 8-K COLLEGIUM PHARMACEUTICAL For: Feb 26
Low
Report
Form 8-K COLLEGIUM PHARMACEUTICAL For: Feb 26
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/6
Collegium Reports Third Quarter 2019 Financial Results
31.4%
2/6 Collegium to Acquire U.S. Rights to Nucynta Franchise 25.4%
3/13 Collegium Pharmaceutical Inc (NASDAQ: COLL) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 15.8%
11/8 Collegium to Participate in Upcoming Investor Conference 13.9%
1/7 Collegium Provides 2020 Financial Guidance 11.0%
2/27 Q4/2019 12/31/2019 EPS -0.070 ZacksConsensus -0.170 ActVsEst 0.100 - Beat 9.5%
4/3 Form 4 COLLEGIUM PHARMACEUTICAL For: Apr 01 Filed by: Malamut Richard 8.9%
2/11 Form 424B5 COLLEGIUM PHARMACEUTICAL 8.8%
8/7 Form 8-K COLLEGIUM PHARMACEUTICAL For: Aug 07 7.4%
3/18 Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 16 Filed by: Kuhlmann Shirley R. 5.7%
2/6 Collegium to Acquire U.S. Rights to Nucynta Franchise 25.4%
3/13 Collegium Pharmaceutical Inc (NASDAQ: COLL) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. 15.8%
11/8 Collegium to Participate in Upcoming Investor Conference 13.9%
1/7 Collegium Provides 2020 Financial Guidance 11.0%
2/27 Q4/2019 12/31/2019 EPS -0.070 ZacksConsensus -0.170 ActVsEst 0.100 - Beat 9.5%
4/3 Form 4 COLLEGIUM PHARMACEUTICAL For: Apr 01 Filed by: Malamut Richard 8.9%
2/11 Form 424B5 COLLEGIUM PHARMACEUTICAL 8.8%
8/7 Form 8-K COLLEGIUM PHARMACEUTICAL For: Aug 07 7.4%
3/18 Form 4 COLLEGIUM PHARMACEUTICAL For: Mar 16 Filed by: Kuhlmann Shirley R. 5.7%
TOP News Decliners
2/7
Form 4 COLLEGIUM PHARMACEUTICAL For: Feb 05 Filed by: Malamut Richard
-15.7%
12/2 Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 29 Filed by: Ciaffoni Joseph -6.0%
12/30 Collegium Pharmaceutical Inc (NASDAQ: COLL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock. -5.3%
11/8 Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 07 Filed by: Ciaffoni Joseph -4.9%
5/17 Form 4 COLLEGIUM PHARMACEUTICAL For: May 15 Filed by: Heffernan Michael Thomas -4.3%
8/13 Form 4 COLLEGIUM PHARMACEUTICAL For: Aug 09 Filed by: Fleming Alison B -4.3%
2/13 Collegium Announces Closing of the Nucynta Franchise Acquisition -3.7%
7/16 Collegium Pharmaceutical Inc (NASDAQ: COLL) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -3.6%
3/31 Form EFFECT COLLEGIUM PHARMACEUTICAL -3.5%
7/17 Form 4 COLLEGIUM PHARMACEUTICAL For: Jul 15 Filed by: Heffernan Michael Thomas -3.3%
12/2 Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 29 Filed by: Ciaffoni Joseph -6.0%
12/30 Collegium Pharmaceutical Inc (NASDAQ: COLL) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $28.00 price target on the stock. -5.3%
11/8 Form 4 COLLEGIUM PHARMACEUTICAL For: Nov 07 Filed by: Ciaffoni Joseph -4.9%
5/17 Form 4 COLLEGIUM PHARMACEUTICAL For: May 15 Filed by: Heffernan Michael Thomas -4.3%
8/13 Form 4 COLLEGIUM PHARMACEUTICAL For: Aug 09 Filed by: Fleming Alison B -4.3%
2/13 Collegium Announces Closing of the Nucynta Franchise Acquisition -3.7%
7/16 Collegium Pharmaceutical Inc (NASDAQ: COLL) was downgraded by analysts at BidaskClub from a "hold" rating to a "sell" rating. -3.6%
3/31 Form EFFECT COLLEGIUM PHARMACEUTICAL -3.5%
7/17 Form 4 COLLEGIUM PHARMACEUTICAL For: Jul 15 Filed by: Heffernan Michael Thomas -3.3%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: